Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Peptide Process CMCPeptide Process CMC
Not Confirmed
Not Confirmed
28-30 August, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Not Confirmed
Not Confirmed
01 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Peptide Process CMCPeptide Process CMC
Industry Trade Show
Not Confirmed
28-30 August, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Industry Trade Show
Not Confirmed
01 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
27 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/27/3140005/0/en/Allogene-Therapeutics-Announces-Participation-in-Upcoming-Investor-Conference.html
13 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/13/3132968/0/en/Allogene-Therapeutics-Reports-Second-Quarter-2025-Financial-Results-and-Business-Update.html
05 Aug 2025
// BIOSPACE
https://www.biospace.com/drug-development/allogene-scraps-immunosuppressive-antibody-after-patient-death-in-lymphoma-trial
02 Aug 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/allogene-reports-patient-death-and-discontinues-investigational-antibody-phase-2-trial
01 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/01/3091475/0/en/Allogene-Therapeutics-Provides-Updated-Phase-1-Data-Highlighting-Durable-Responses-with-ALLO-316-in-Heavily-Pretreated-Advanced-Renal-Cell-Carcinoma-at-ASCO.html
23 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/23/3087458/0/en/Allogene-Therapeutics-Announces-Participation-in-Upcoming-Investor-Conferences.html
ABOUT THIS PAGE